Vnitr Lek 2014, 60(1):22-24

Terapie těžké sepse v roce 2013 - editorial

Jan Maláska
Klinika anesteziologie, resuscitace a intenzivní medicíny LF MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Roman Gál, Ph.D.

Received: December 16, 2013; Published: January 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maláska J. Terapie těžké sepse v roce 2013 - editorial. Vnitr Lek. 2014;60(1):22-24.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29(7): 1303-1310. Go to original source... Go to PubMed...
    2. HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009. Rockville, MD: Healthcare Cost and Utilization Project (HCUP); 2011. Dostupné na WWW: <http://hcup-us.ahrq.gov/reports/factsandfigures/2009/TOC_2009.jsp.>
    3. Time to act. Severe sepsis: rapid diagnosis and treatment saves lives. Dostupné na WWW: http://www.ombudsman.org.uk/__data/assets/pdf_file/0004/22666/FINAL_Sepsis_Report_web.pdf.
    4. Maláska J, Slezák M, Schwarz D et al. Léčba těžké sepse na pracovištích intenzivní péče v České republice - pilotní výsledky projektu EPOSS. Vnitř Lék 2013; 59(11): 962-970. Go to PubMed...
    5. Chalupka AN, Talmor D. The economics of sepsis. Crit Care Clin 2012; 28(1): 57-76. Go to original source... Go to PubMed...
    6. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32(3): 858-873. Go to original source... Go to PubMed...
    7. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis - practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 2006; 355(16): 1640-1642. Go to original source... Go to PubMed...
    8. Hicks P, Cooper DJ. The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Resusc 2008; 10(1): 8. Go to original source... Go to PubMed...
    9. Levy MM, Dellinger RP, Townsend SR et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36(2): 222-231. Go to original source... Go to PubMed...
    10. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41(2): 580-637. Go to original source... Go to PubMed...
    11. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39(2): 165-228. Go to original source... Go to PubMed...
    12. Chvojka J, Matějovič M. Mezinárodní doporučení pro léčbu těžké sepse a septického šoku 2012 - komentovaný výběr. Vnitř Lék 2014; 60: 59-67. Go to PubMed...
    13. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924-926. Go to original source... Go to PubMed...
    14. Wollersheim H, Burgers J, Grol R. Clinical guidelines to improve patient care. Neth J Med 2005; 63(6): 188-192.
    15. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134(1): 172-178. Go to original source... Go to PubMed...
    16. Ledvinová L, Danihel V, Matějovič M. Perspektivní přístupy v léčbě sepse založené na principu nových patogenetických poznatků. Vnitř Lék 2014; 60: 68-72. Go to PubMed...
    17. Freeman BD, Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 2000; 9(7): 1651-1663. Go to original source... Go to PubMed...
    18. Dellinger RP. Severe sepsis trials: why have they failed? Minerva Anestesiol 1999; 65(6): 340-345. Go to PubMed...
    19. Ranieri VM, Thompson BT, Barie PS et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366(2): 2055-2064. Go to original source... Go to PubMed...
    20. Thorburn WM. The Myth of Occam's Razor. Mind 1918; 27(3): 345-353. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.